Dr. Emese Zsiros
Claim this profileRoswell Park Cancer Institute
Studies Ovarian Cancer
Studies Fallopian Tube Cancer
12 reported clinical trials
20 drugs studied
Area of expertise
1Ovarian Cancer
Stage IV
Stage III
Stage II
2Fallopian Tube Cancer
Stage II
Stage III
Stage IV
Affiliated Hospitals
Clinical Trials Emese Zsiros is currently running
APL-2 + Pembrolizumab +/- Bevacizumab
for Ovarian Cancer
This trial tests APL-2 alone or with other drugs in patients with recurrent ovarian, fallopian tube, or primary peritoneal cancer that causes fluid buildup. APL-2 aims to slow tumor growth, reduce fluid buildup, and enhance the immune response. The study aims to determine the most effective treatment.
Recruiting1 award Phase 212 criteria
Iohexol-aided Carboplatin Dosing
for Cancer
This trial studies how well iohexol helps doctors calculate the dose of carboplatin for cancer patients. By measuring kidney function more accurately, doctors can improve the effectiveness and safety of carboplatin treatment. Carboplatin is a platinum-based chemotherapy drug used to treat various cancers, known for its improved toxicity profile compared to cisplatin.
Recruiting1 award Phase 17 criteria
More about Emese Zsiros
Clinical Trial Related4 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Emese Zsiros has experience with
- Pembrolizumab
- Bevacizumab
- Nivolumab
- Ipilimumab
- Decitabine
- Genetically Engineered NY-ESO-1-specific T Lymphocytes
Breakdown of trials Emese Zsiros has run
Ovarian Cancer
Fallopian Tube Cancer
Peritoneal Carcinoma
Ovarian Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Emese Zsiros specialize in?
Emese Zsiros focuses on Ovarian Cancer and Fallopian Tube Cancer. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are Stage III.
Is Emese Zsiros currently recruiting for clinical trials?
Yes, Emese Zsiros is currently recruiting for 6 clinical trials in Buffalo New York. If you're interested in participating, you should apply.
Are there any treatments that Emese Zsiros has studied deeply?
Yes, Emese Zsiros has studied treatments such as Pembrolizumab, Bevacizumab, Nivolumab.
What is the best way to schedule an appointment with Emese Zsiros?
Apply for one of the trials that Emese Zsiros is conducting.
What is the office address of Emese Zsiros?
The office of Emese Zsiros is located at: Roswell Park Cancer Institute, Buffalo, New York 14263 United States. This is the address for their practice at the Roswell Park Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.